1nms
|
Caspase-3 tethered to irreversible inhibitor
OverviewOverview
Cysteine aspartyl protease-3 (caspase-3) is a mediator of apoptosis and a, therapeutic target for a wide range of diseases. Using a dynamic, combinatorial technology, 'extended tethering', we identified unique, nonpeptidic inhibitors for this enzyme. Extended tethering allowed the, identification of ligands that bind to discrete regions of caspase-3 and, also helped direct the assembly of these ligands into small-molecule, inhibitors. We first designed a small-molecule 'extender' that, irreversibly alkylates the cysteine residue of caspase-3 and also contains, a thiol group. The modified protein was then screened against a library of, disulfide-containing small-molecule fragments. Mass-spectrometry was used, to identify ligands that bind noncovalently to the protein and that also, form a disulfide linkage with the extender. Linking the selected fragments, with binding elements from the extenders generates reversible, tight-binding molecules that are druglike and distinct from known, inhibitors. One molecule derived from this approach inhibited apoptosis in, cells.
About this StructureAbout this Structure
1NMS is a Single protein structure of sequence from Homo sapiens with 161 as ligand. Full crystallographic information is available from OCA.
ReferenceReference
In situ assembly of enzyme inhibitors using extended tethering., Erlanson DA, Lam JW, Wiesmann C, Luong TN, Simmons RL, DeLano WL, Choong IC, Burdett MT, Flanagan WM, Lee D, Gordon EM, O'Brien T, Nat Biotechnol. 2003 Mar;21(3):308-14. Epub 2003 Feb 3. PMID:12563278
Page seeded by OCA on Mon Nov 12 18:22:54 2007